Literature DB >> 33602697

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis.

Margaret Gatti-Mays1, James L Gulley2.   

Abstract

Entities:  

Keywords:  guidelines as topic; immunotherapy; programmed cell death 1 receptor

Mesh：

Substances：

Year:  2021        PMID： 33602697      PMCID： PMC7896600          DOI： 10.1136/jitc-2020-002252

Source DB:  PubMed          Journal:  J Immunother Cancer        ISSN： 2051-1426            Impact factor:   13.751


× No keyword cloud information.
  10 in total

1.  Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J B A G Haanen; F Carbonnel; C Robert; K M Kerr; S Peters; J Larkin; K Jordan
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

Review 2.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

3.  NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Authors:  John A Thompson; Bryan J Schneider; Julie Brahmer; Stephanie Andrews; Philippe Armand; Shailender Bhatia; Lihua E Budde; Luciano Costa; Marianne Davies; David Dunnington; Marc S Ernstoff; Matthew Frigault; Benjamin H Kaffenberger; Matthew Lunning; Suzanne McGettigan; Jordan McPherson; Nisha A Mohindra; Jarushka Naidoo; Anthony J Olszanski; Olalekan Oluwole; Sandip P Patel; Nathan Pennell; Sunil Reddy; Mabel Ryder; Bianca Santomasso; Scott Shofer; Jeffrey A Sosman; Yinghong Wang; Ryan M Weight; Alyse Johnson-Chilla; Griselda Zuccarino-Catania; Anita Engh
Journal:  J Natl Compr Canc Netw       Date:  2020-03       Impact factor: 11.908

Review 4.  Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.

Authors:  Filipe Martins; Latifyan Sofiya; Gerasimos P Sykiotis; Faiza Lamine; Michel Maillard; Montserrat Fraga; Keyvan Shabafrouz; Camillo Ribi; Anne Cairoli; Yan Guex-Crosier; Thierry Kuntzer; Olivier Michielin; Solange Peters; Georges Coukos; Francois Spertini; John A Thompson; Michel Obeid
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

Review 5.  Immune-related adverse events with immune checkpoint blockade: a comprehensive review.

Authors:  J M Michot; C Bigenwald; S Champiat; M Collins; F Carbonnel; S Postel-Vinay; A Berdelou; A Varga; R Bahleda; A Hollebecque; C Massard; A Fuerea; V Ribrag; A Gazzah; J P Armand; N Amellal; E Angevin; N Noel; C Boutros; C Mateus; C Robert; J C Soria; A Marabelle; O Lambotte
Journal:  Eur J Cancer       Date:  2016-01-05       Impact factor: 9.162

6.  Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.

Authors:  Daniel Y Wang; Joe-Elie Salem; Justine V Cohen; Sunandana Chandra; Christian Menzer; Fei Ye; Shilin Zhao; Satya Das; Kathryn E Beckermann; Lisa Ha; W Kimryn Rathmell; Kristin K Ancell; Justin M Balko; Caitlin Bowman; Elizabeth J Davis; David D Chism; Leora Horn; Georgina V Long; Matteo S Carlino; Benedicte Lebrun-Vignes; Zeynep Eroglu; Jessica C Hassel; Alexander M Menzies; Jeffrey A Sosman; Ryan J Sullivan; Javid J Moslehi; Douglas B Johnson
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

7.  Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Authors:  I Puzanov; A Diab; K Abdallah; C O Bingham; C Brogdon; R Dadu; L Hamad; S Kim; M E Lacouture; N R LeBoeuf; D Lenihan; C Onofrei; V Shannon; R Sharma; A W Silk; D Skondra; M E Suarez-Almazor; Y Wang; K Wiley; H L Kaufman; M S Ernstoff
Journal:  J Immunother Cancer       Date:  2017-11-21       Impact factor: 13.751

Review 8.  Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.

Authors:  Mizuki Nishino; Anita Giobbie-Hurder; Hiroto Hatabu; Nikhil H Ramaiya; F Stephen Hodi
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

9.  Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.

Authors:  Jason Beattie; Hira Rizvi; Paige Fuentes; Jia Luo; Adam Schoenfeld; I-Hsin Lin; Michael Postow; Margaret Callahan; Martin H Voss; Neil J Shah; Allison Betof Warner; Mohit Chawla; Matthew D Hellmann
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

10.  Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.

Authors:  Aanika Balaji; Melinda Hsu; Karthik Suresh; Jarushka Naidoo; Cheng Ting Lin; Josephine Feliciano; Kristen Marrone; Julie R Brahmer; Patrick M Forde; Christine Hann; Lei Zheng; Valerie Lee; Peter B Illei; Sonye K Danoff
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 12.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.